Kisspeptin
ReproductiveKisspeptin-10 — Synthetic Peptide
Overview
Kisspeptin is a neuropeptide produced by KNDy neurons (kisspeptin/neurokinin B/dynorphin neurons) in the arcuate nucleus of the hypothalamus. It is encoded by the KISS1 gene and acts on KISS1R (GPR54) receptors on hypothalamic GnRH neurons, making it the master upstream regulator of the hypothalamic-pituitary-gonadal axis. Kisspeptin is investigational for reproductive disorders including hypothalamic amenorrhea, IVF oocyte triggering, and idiopathic hypogonadotropic hypogonadism; no therapeutic form has received regulatory approval.
The most studied forms are kisspeptin-10 (KP-10, 10 amino acids, C-terminal fragment) and kisspeptin-54 (KP-54, 54 amino acids, full-length). Both bind KISS1R with equivalent receptor-level potency; KP-54 has longer plasma half-life. The sequence listed above is KP-10 (the research-grade vendor form typically sold as lyophilized powder).
Mechanism of Action
Kisspeptin binds KISS1R, a Gαq-coupled GPCR expressed specifically on GnRH neurons in the hypothalamus. KISS1R activation → Gαq → PLC → IP3 → Ca²⁺ release → GnRH vesicle exocytosis → pulsatile GnRH secretion into the hypothalamic-pituitary portal circulation → LH/FSH release → gonadal steroidogenesis.
KNDy neurons in the arcuate nucleus form the GnRH pulse generator through an autocrine/paracrine circuit: - **Kisspeptin:** Excitatory; drives GnRH pulse initiation - **Neurokinin B (NKB):** Excitatory; amplifies KNDy synchronization - **Dynorphin:** Inhibitory; terminates GnRH pulse and resets cycle
This coordinated circuit produces the ~90-minute GnRH pulse frequency critical for normal gonadotropin secretion. Loss of kisspeptin signaling (KISS1/KISS1R null mutations) causes complete hypogonadotropic hypogonadism. The KNDy model also explains menopausal hot flashes: estrogen withdrawal disinhibits NKB signaling in the same neurons, driving dysregulated thermogenesis — the mechanistic basis for fezolinetant (NKB antagonist, FDA-approved 2023 for menopausal vasomotor symptoms).
Sex steroid feedback operates through kisspeptin: estrogen negative feedback (cycle phase) and the preovulatory estrogen positive feedback surge both act on KISS1R-expressing neurons, with kisspeptin mediating the LH surge that triggers ovulation.
Research Dosing
Kisspeptin-10 (KP-10) and kisspeptin-54 (KP-54) are both used in clinical research. Pulsatile IV administration at 90-minute intervals restores gonadotropin secretion in hypothalamic amenorrhea. Used as IVF oocyte trigger (4 nmol/kg IV) in Phase 2 trials to avoid OHSS.
No approved SC formulation exists. Kisspeptin-54 has longer plasma half-life than KP-10. SC administration produces sustained LH/FSH stimulation in healthy volunteers.
Research data only. These dosing ranges are derived from published studies, primarily in animal models. This is not medical advice. No peptide discussed on this site is approved for human therapeutic use unless otherwise noted.
Published Studies
Clinical applications of kisspeptin in reproductive medicine
Bhattacharya SM, Jain A — Reproductive Biology and Endocrinology, 2022
Comprehensive review of kisspeptin's role as the master GnRH regulator and its Phase 2 clinical applications: IVF oocyte triggering (reduces OHSS risk vs. hCG), hypothalamic amenorrhea (restores gonadotropin pulsatility), and PCOS. Established kisspeptin as the most physiologically proximal target for fertility intervention.
PMID: 35606759 →ReviewKNDy neurons and kisspeptin control of GnRH pulsatility
Clarkson J, Han SY, Piet R, et al. — Frontiers in Endocrinology, 2022
Delineated the KNDy neuron model (kisspeptin + neurokinin B + dynorphin in arcuate nucleus) as the primary GnRH pulse generator. KISS1 and KISS1R loss-of-function mutations cause idiopathic hypogonadotropic hypogonadism; gain-of-function mutations cause precocious puberty — establishing kisspeptin as a causal HPG regulator, not merely a modulator.
PMID: 35837314 →HumanSubcutaneous and intravenous kisspeptin administration stimulates LH and FSH in healthy volunteers
Dhillo WS, Chaudhri OB, Patterson M, et al. — Neuroendocrinology, 2015
Human pharmacokinetic and pharmacodynamic study of kisspeptin-54 demonstrating dose-dependent LH/FSH stimulation after both SC and IV administration, with SC route producing a sustained gonadotropin response — establishing human PK/PD parameters for therapeutic development.
PMID: 26277870 →